Peripheral arterial disease: Morbidity and mortality implications, Circulation, vol.114, pp.688-699, 2006. ,
TASC II Working Group Inter-society consensus for the management of peripheral arterial disease, Int. Angiol. J. Int. Union Angiol, vol.26, pp.81-157, 2007. ,
Peripheral arterial disease-What do we need to know?, Clin. Cardiol, vol.34, pp.478-482, 2011. ,
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis, Lancet, vol.382, pp.1329-1340, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00925590
Stent Placement vs. Balloon Angioplasty for Popliteal Artery Treatment: Two-Year Results of a Prospective, Multicenter, Randomized Trial, J. Endovasc. Ther. Off. J. Int. Soc. Endovasc. Spec, vol.22, pp.22-27, 2015. ,
Development and tissue specialization, Annu. Rev. Immunol, vol.33, pp.643-675, 2015. ,
Living in a medically underserved county is an independent risk factor for major limb amputation, J. Vasc. Surg, vol.59, pp.737-741, 2014. ,
Peripheral artery disease. Part 1: Clinical evaluation and noninvasive diagnosis, Nat. Rev. Cardiol, vol.8, pp.405-418, 2011. ,
The ankle-brachial index and the diabetic foot: A troublesome marriage, Ann. Vasc. Surg, vol.25, pp.770-777, 2011. ,
Peripheral artery disease. Part 2: Medical and endovascular treatment, Nat. Rev. Cardiol, vol.8, pp.429-441, 2011. ,
Critical limb ischemia: Definition and natural history, Curr. Drug Targets Cardiovasc. Haematol. Disord, vol.4, pp.219-225, 2004. ,
Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group, Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg, vol.18, pp.401-410, 1999. ,
Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia, Mol. Ther. J. Am. Soc. Gene Ther, vol.17, pp.914-921, 2009. ,
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease, Vasc. Med. Lond. Engl, vol.15, pp.171-179, 2010. ,
TALISMAN 201 investigators Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia, Mol. Ther. J. Am. Soc. Gene Ther, vol.16, pp.972-978, 2008. ,
TAMARIS Committees and Investigators Effect of fibroblast growth factor NV1FGF on amputation and death: A randomised placebo-controlled trial of gene therapy in critical limb ischaemia, Lancet, vol.377, pp.1929-1937, 2011. ,
TRAFFIC Investigators Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): A randomised trial, Lancet, vol.359, pp.2053-2058, 2002. ,
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication, Circulation, vol.108, pp.1933-1938, 2003. ,
Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial, Lancet, vol.360, pp.427-435, 2002. ,
Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia, Circ. J. Off. J. Jpn. Circ. Soc, vol.69, pp.1260-1265, 2005. ,
Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes, Diabetes Care, vol.28, pp.2155-2160, 2005. ,
Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature, Atherosclerosis, vol.209, pp.10-17, 2010. ,
Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia, Cochrane Database Syst. Rev, vol.12, p.8347, 2011. ,
Postischemic revascularization: From cellular and molecular mechanisms to clinical applications, Physiol. Rev, vol.93, pp.1743-1802, 2013. ,
Elevated monocytes in patients with critical limb ischemia diminish after bypass surgery, J. Surg. Res, vol.167, pp.140-150, 2011. ,
G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism, Blood, vol.108, pp.2438-2445, 2006. ,
Blood monocyte concentration is critical for enhancement of collateral artery growth, Am. J. Physiol. Heart Circ. Physiol, vol.283, pp.2411-2419, 2002. ,
Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2, Circ. Res, vol.94, pp.671-677, 2004. ,
Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1, Am. J. Physiol. Heart Circ. Physiol, vol.284, pp.1422-1428, 2003. ,
Therapeutic effect of fucoidan-stimulated endothelial colony-forming cells in peripheral ischemia, J. Thromb. Haemost. JTH, vol.10, pp.38-48, 2012. ,
Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential, Arterioscler. Thromb. Vasc. Biol, vol.28, pp.644-650, 2008. ,
Neoangiogenesis induced by progenitor endothelial cells: Effect of fucoidan from marine algae, Cardiovasc. Hematol. Agents Med. Chem, vol.5, pp.67-77, 2007. ,
Low-molecular-weight fucoidan promotes therapeutic revascularization in a rat model of critical hindlimb ischemia, J. Pharmacol. Exp. Ther, vol.305, pp.24-30, 2003. ,
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions, J. Exp. Med, vol.204, pp.3037-3047, 2007. ,
Blood monocytes consist of two principal subsets with distinct migratory properties, Immunity, vol.19, pp.71-82, 2003. ,
Arhgef1 regulates alpha5beta1 integrin-mediated matrix metalloproteinase expression and is required for homeostatic lung immunity, Am. J. Pathol, vol.176, pp.1157-1168, 2010. ,
Leukocyte migration into inflamed tissues, Immunity, vol.41, pp.694-707, 2014. ,
Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice, J. Leukoc. Biol, vol.80, pp.59-65, 2006. ,
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb, J. Clin. Invest, vol.101, pp.40-50, 1998. ,
Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-beta1 in healing rat vein grafts, J. Vasc. Surg, vol.39, pp.878-888, 2004. ,
Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo, Arterioscler. Thromb. Vasc. Biol, vol.26, pp.2063-2069, 2006. ,
Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation, J. Vasc. Surg, vol.45, pp.1236-1243, 2007. ,
In vitro effects of fucans on MDA-MB231 tumor cell adhesion and invasion, Anticancer Res, vol.22, pp.2285-2292, 2002. ,
Characterization of the stromal cell-derived factor-1alpha-heparin complex, J. Biol. Chem, vol.276, pp.8288-8296, 2001. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00166877
The polysaccharide fucoidan inhibits microvascular thrombus formation independently from P-and L-selectin function in vivo, Eur. J. Clin. Invest, vol.30, pp.804-810, 2000. ,
Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: Evidence for selectin-dependent and independent mechanisms, Blood, vol.96, pp.2460-2468, 2000. ,
Signal transduction involved in MCP-1-mediated monocytic transendothelial migration, Blood, vol.97, pp.359-366, 2001. ,
Functional Relevance of Protein Glycosylation to the Pro-Inflammatory Effects of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) on Monocytes/Macrophages, PLoS ONE, vol.10, p.117463, 2015. ,
Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis, J. Biol. Chem, vol.276, pp.16555-16560, 2001. ,
Monocyte adhesion and transmigration induce tissue factor expression: Role of the mitogen-activated protein kinases, Shock, vol.18, pp.51-57, 2002. ,
Recombinant protein rVP1 upregulates BECN1-independent autophagy, MAPK1/3 phosphorylation and MMP9 activity via WIPI1/WIPI2 to promote macrophage migration, Autophagy, vol.9, pp.5-19, 2013. ,
Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells, Cytotechnology, vol.47, pp.117-126, 2005. ,
Fucoidan from Seaweed Fucus vesiculosus Inhibits Migration and Invasion of Human Lung Cancer Cell via PI3K-Akt-mTOR Pathways, PLoS ONE, vol.7, p.50624, 2012. ,
Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma, Mar. Drugs, vol.13, pp.3514-3530, 2015. ,
Therapies from fucoidan; Multifunctional marine polymers, Mar. Drugs, vol.9, pp.1731-1760, 2011. ,
Fucoidans: Pro-or antiangiogenic agents?, Glycobiology, vol.24, pp.1265-1274, 2014. ,
Effects of middle molecular weight fucoidans on in vitro and ex vivo angiogenesis of endothelial cells, Int. J. Mol. Med, vol.15, pp.695-699, 2005. ,
Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells, Biochem. Pharmacol, vol.70, pp.1167-1175, 2005. ,
Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum, Carbohydr. Res, vol.289, pp.201-208, 1996. ,
Molecular weight measurements of low molecular weight heparins by gel permeation chromatography, Thromb. Haemost, vol.77, pp.668-674, 1997. ,